Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cencora, Inc. Common Stock
(NY:
COR
)
324.84
-0.24 (-0.07%)
Streaming Delayed Price
Updated: 9:40 AM EDT, Mar 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cencora, Inc. Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
$1000 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
↗
March 29, 2024
Via
Benzinga
Here's How Much $100 Invested In Cencora 10 Years Ago Would Be Worth Today
↗
March 13, 2024
Via
Benzinga
Cencora Announces Leadership Succession Plan
March 12, 2024
From
Cencora
Via
Business Wire
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
↗
February 28, 2024
Via
Benzinga
Critical Insights From Cencora Analyst Ratings: What You Need To Know
↗
February 26, 2024
Via
Benzinga
US Federal Trade Commission Investigates Drug Shortages Amid Allegations Of Market Manipulation
↗
February 14, 2024
FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scrutiny. Industry defends practices.
Via
Benzinga
Here's How Much $1000 Invested In Cencora 5 Years Ago Would Be Worth Today
↗
February 09, 2024
Via
Benzinga
Wednesday Is Your Last Chance To Buy Cencora Before The Dividend Payout
↗
February 05, 2024
Via
Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $12,000 Today
↗
February 02, 2024
Via
Benzinga
Why Walgreens Boots Alliance Stock Slumped 13.6% in January
↗
February 08, 2024
The pharmacy giant ended an era.
Via
The Motley Fool
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
February 07, 2024
From
Cencora
Via
Business Wire
Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
February 07, 2024
From
Walgreens Boots Alliance
Via
Business Wire
Cencora Closes $500 Million Senior Notes Offering
February 07, 2024
From
Cencora
Via
Business Wire
Peering Into Cencora's Recent Short Interest
↗
February 01, 2024
Via
Benzinga
How Is The Market Feeling About Cencora?
↗
January 11, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 20 Years
↗
January 05, 2024
Via
Benzinga
Cencora Prices $500 Million 5.125% Senior Notes Due 2034
February 05, 2024
From
Cencora
Via
Business Wire
Drug Wholesale Firm Cencora Starts 2024 With Strong Growth, Lifts Annual Forecast On Commercial COVID-19 Vaccine Distribution
↗
January 31, 2024
Cencora reports Q1 2024 results with adjusted EPS at $3.28 and revenue of $72.3 billion. Explore the company's fiscal year 2024 guidance and growth projections.
Via
Benzinga
Cencora Reports Fiscal 2024 First Quarter Results
January 31, 2024
From
Cencora
Via
Business Wire
Chart Of The Day: Cencora - Name Changed To Protect The Innocent?
↗
January 17, 2024
Cencora, Inc. sources and distributes pharmaceutical products.
Via
Talk Markets
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today
↗
December 18, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Cencora Stock In The Last 15 Years
↗
December 06, 2023
Via
Benzinga
(COR) - Analyzing Cencora's Short Interest
↗
December 05, 2023
Via
Benzinga
Earnings Scheduled For January 31, 2024
↗
January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,300 Today
↗
November 21, 2023
Via
Benzinga
Is AI More Valuable In Advertising Than Healthcare? Jim Cramer Questions Wall Street's Preference
↗
January 10, 2024
Cramer shared his insights during his attendance at JPMorgan's healthcare conference,
Via
Benzinga
Topics
Artificial Intelligence
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
January 04, 2024
From
Cencora
Via
Business Wire
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
↗
December 04, 2023
New growth drivers are helping to propel these reliable and steady businesses.
Via
The Motley Fool
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'
↗
November 29, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the way up here.
Via
Benzinga
Teva Pharma is the way to play the re-rise of generic drugs
November 28, 2023
Generic and specialty pharmaceutical company, Teva Pharmaceutical's stock, has underperformed for years, but a potential spinoff may be a catalyst for growth
Via
MarketBeat
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
